Results 1 to 10 of about 3,564,161 (186)

Revisiting promyelocytic leukemia protein targeting by human cytomegalovirus immediate-early protein 1. [PDF]

open access: yesPLoS Pathogens, 2020
Promyelocytic leukemia (PML) bodies are nuclear organelles implicated in intrinsic and innate antiviral defense. The eponymous PML proteins, central to the self-organization of PML bodies, and other restriction factors found in these organelles are ...
Christina Paulus   +6 more
doaj   +2 more sources

Characterization and functional analysis of chicken promyelocytic leukemia protein [PDF]

open access: yesPoultry Science
: In mammals, promyelocytic leukemia (PML) protein, also named as TRIM19, is the key component of nuclear membrane-less sub structures PML nuclear bodies (PML-NB) or nuclear domains 10 (ND10). PML-NBs are dynamic foci that consist of numerous permanently
Shengnan Wang   +8 more
doaj   +2 more sources

Promyelocytic Leukemia Protein (PML) Controls Listeria monocytogenes Infection [PDF]

open access: yesmBio, 2017
The promyelocytic leukemia protein (PML) is the main organizer of stress-responsive subnuclear structures called PML nuclear bodies. These structures recruit multiple interactors and modulate their abundance or their posttranslational modifications ...
David Ribet   +6 more
doaj   +2 more sources

Nucleoporin 98 Rearrangements in Acute Leukemia: A Genomic Landscape Study. [PDF]

open access: yesHematol Oncol
ABSTRACT Nucleoporin 98 rearrangements (NUP98re) occur in a wide range of hematologic malignancies including acute leukemias with a variety of fusion partners. NUP98re is associated with adverse prognosis, especially in children. We aimed to better understand the genomics of acute leukemias with NUP98re including fusion partners and co‐occurring ...
Batayneh O   +10 more
europepmc   +2 more sources

Promyelocytic Leukemia Protein Is an Essential Regulator of Stem Cell Pluripotency and Somatic Cell Reprogramming. [PDF]

open access: yesStem Cell Reports, 2017
Hadjimichael C   +7 more
europepmc   +2 more sources

Acute promyelocytic leukemia. State of the art

open access: yesIatreia, 2021
Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) that results from a balanced translocation between chromosomes 15 and 17, which involves the gene encoding the retinoic acid receptor alpha (RARA) on chromosome 17 and the ...
Leonardo Mejía-Buriticá   +2 more
doaj   +1 more source

Biomolecular Condensates in Myeloid Leukemia: What Do They Tell Us?

open access: yesHemaSphere, 2023
Recent studies have suggested that several oncogenic and tumor-suppressive proteins carry out their functions in the context of specific membrane-less cellular compartments.
Zivojin Jevtic   +3 more
doaj   +1 more source

Case Report: Identification of a novel LYN::LINC01900 transcript with promyelocytic phenotype and TP53 mutation in acute myeloid leukemia

open access: yesFrontiers in Oncology, 2023
Acute myeloid leukemia (AML) is a malignant disease of myeloid hematopoietic stem/progenitor cells characterized by the abnormal proliferation of primitive and naive random cells in the bone marrow and peripheral blood. Acute promyelocytic leukemia (APL)
Chengjun Hu   +9 more
doaj   +1 more source

The CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylated

open access: yesHaematologica, 2011
Impairment of CCAAT Enhancer Binding Protein alpha (CEBPA) function is a common finding in acute myeloid leukemia; nevertheless, its relevance for acute promyelocytic leukemia pathogenesis is unclear.
Bárbara Amélia Santana-Lemos   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy